Kristen Nubia Kaba

An Overview of COVID-19 Vaccines: Challenges of the Discovery and Development by the Pharmaceutical Industries

Estella Achick Tembe-Fokunang, Andrew Nyuyki Banin, Joseph Fokam, Dobgima John Fonmboh, Kristen Nubia Kaba, Lovet Benyella Fokunang, Ben Enoluomen Ehigiator, Zelinjo N. Igweze, Sarah Tishkoff, Ralf Duerr & Charles Ntungwen Fokunang · International Journal of Pathogen Research · 2022

The coronavirus (COVID-19) took the world by storm and triggered intensive research mobilization and action towards vaccines and drug repurposing. This pandemic triggered an emergence therapy intervention of which the development of new vaccine and drug repurposing were good opti...

Open access Research Article 10.9734/ijpr/2022/v11i2209

An Overview of Pharmacovigilance and Adverse Drug Reaction Monitoring of Drugs and Vaccines during the COVID-19 Pandemic

Estella Achick Tembe-Fokunang, Banin Andrew Nyuki, Joseph Fokam, Dobgima John Fonmboh, Kristen Nubia Kaba, Lovet Benyella Fokunang, François-Xavier Mbopi-Keou, Abena, Ondoua Obama Marie Therese, Ralf Duerr & Charles Ntungwen Fokunang · Journal of Advances in Medical and Pharmaceutical Sciences · 2022

Once a drug is approved in phase III of clinical trials, pharmacovigilance (PV) becomes very important for the surveillance of drug, vaccine or medical devices. PV constitutes part of the phase IV approval, which involves a study for collecting, detecting, and monitoring adverse...

Open access Research Article 10.9734/jamps/2022/v24i630308